Статті в журналах з теми "[004.7"

Щоб переглянути інші типи публікацій з цієї теми, перейдіть за посиланням: [004.7.

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся з топ-50 статей у журналах для дослідження на тему "[004.7".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.

1

Thomas⁎, Pierre. "[0047] JME “live”." Epilepsy & Behavior 28 (July 2013): S91. http://dx.doi.org/10.1016/j.yebeh.2012.11.010.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
2

Burgaz, Sonia, Concepción García, María Gómez-Cañas, Alain Rolland, Eduardo Muñoz, and Javier Fernández-Ruiz. "Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease." Molecules 26, no. 11 (May 28, 2021): 3245. http://dx.doi.org/10.3390/molecules26113245.

Повний текст джерела
Анотація:
The 3-hydroxyquinone derivative of the non-psychotrophic phytocannabinoid cannabigerol, so-called VCE-003.2, and some other derivatives have been recently investigated for neuroprotective properties in experimental models of Parkinson’s disease (PD) in mice. The pharmacological effects in those models were related to the activity on the peroxisome proliferator-activated receptor-γ (PPAR-γ) and possibly other pathways. In the present study, we investigated VCE-004.8 (formulated as EHP-101 for oral administration), the 3-hydroxyquinone derivative of cannabidiol (CBD), with agonist activity at the cannabinoid receptor type-2 (CB2) receptor in addition to its activity at the PPAR-γ receptor. Studies were conducted in both in vivo (lesioned-mice) and in vitro (SH-SY5Y cells) models using the classic parkinsonian neurotoxin 6-hydroxydopamine (6-OHDA). Our data confirmed that the treatment with VCE-004.8 partially reduced the loss of tyrosine hydroxylase (TH)-positive neurons measured in the substantia nigra of 6-OHDA-lesioned mice, in parallel with an almost complete reversal of the astroglial (GFAP) and microglial (CD68) reactivity occurring in this structure. Such neuroprotective effects attenuated the motor deficiencies shown by 6-OHDA-lesioned mice in the cylinder rearing test, but not in the pole test. Next, we explored the mechanism involved in the beneficial effect of VCE-004.8 in vivo, by analyzing cell survival in cultured SH-SY5Y cells exposed to 6-OHDA. We found an important cytoprotective effect of VCE-004.8 at a concentration of 10 µM, which was completely reversed by the addition of antagonists, T0070907 and SR144528, aimed at blocking PPAR-γ and CB2 receptors, respectively. The treatment with T0070907 alone only caused a partial reversal, whereas SR144528 alone had no effect, indicating a major contribution of PPAR-γ receptors in the cytoprotective effect of VCE-004.8 at 10 µM. In summary, our data confirmed the neuroprotective potential of VCE-004.8 in 6-OHDA-lesioned mice, and in vitro studies confirmed a greater relevance for PPAR-γ receptors rather than CB2 receptors in these effects.
Стилі APA, Harvard, Vancouver, ISO та ін.
3

Zhang, Zhenyu, Ming Li, Xiaoyin Zhang, Nan Zheng, Shengguo Zhao, and Jiaqi Wang. "A Novel Urease Inhibitor of Ruminal Microbiota Screened through Molecular Docking." International Journal of Molecular Sciences 21, no. 17 (August 20, 2020): 6006. http://dx.doi.org/10.3390/ijms21176006.

Повний текст джерела
Анотація:
Inhibition of the urease activity of ruminal microbiota is not only beneficial for increasing dietary and endogenic urea-N utilization efficiency in ruminants but also might be applicable for the preservation of nitrogen fertilizer in soil and treatment of gastrointestinal and urinary tract infections caused by ureolytic bacteria. To discover urease inhibitors to efficiently target ruminal microbiota, the identified ruminal microbial metagenomic urease gene was used to construct a homology model to virtually screen urease inhibitors from the ChemDiv database by molecular docking. The GMQE and QMEAN values of the homology model were 0.85 and −0.37, respectively, indicating a good model quality. The inhibition effect of the screened urease inhibitor for ruminal urea degradation was assessed by ruminal microbial fermentation in vitro. The toxic effect of the candidate inhibitor was performed using gut Caco-2 cells in vitro. The results showed that compound 3-[1-[(aminocarbonyl)amino]-5-(4-methoxyphenyl)-1H-pyrrol-2-yl] propanoic acid (ChemDiv_ID: 6238-0047, IC50 = 65.86 μM) was found to be the most effective urease inhibitor among the candidate compounds. Compound 6238-0047 significantly lowered the amount of urea degradation and ammonia production in ruminal microbial fermentation. The 24 h degradation rate of compound 6238-0047 in ruminal microbial fermentation was 3.32%–16.00%. In addition, compound 6238-0047 (10–100 μM) had no significant adverse effect on the cell viability of Caco-2 cells. Molecular docking showed that compound 6238-0047 could interact with Asp359 in the active site and Cys318 in the flap region by the hydrogen bond and Pi-Alkyl interaction, respectively. Compound 6238-0047 could be used as a novel inhibitor for decreasing the urease activity of ruminal microbiota.
Стилі APA, Harvard, Vancouver, ISO та ін.
4

da Empoli, Domenico. "Levy, J. P., Le Destin de l’Autorité Internationale des Fonds Marins." Journal of Public Finance and Public Choice 21, no. 2 (October 1, 2003): 213–16. http://dx.doi.org/10.1332/251569203x15668905422072.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
5

Werth, Nicolas. "Massacre sur quotas : "l’opération 00447" (URSS, 1937-1938)." Histoire@Politique 26, no. 2 (2015): 30. http://dx.doi.org/10.3917/hp.026.0030.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
6

Inskip, K. J., K. Jahnke, H. W. Rix та C. Y. Peng. "An Hα Dynamical Mass for HE 0047–1756". Proceedings of the International Astronomical Union 5, S267 (серпень 2009): 205. http://dx.doi.org/10.1017/s1743921310006253.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
7

Warren, S. J., A. Iovino, P. C. Hewett, and P. A. Shaver. "Spectroscopy of the optical Einstein ring 0047 - 2808." Monthly Notices of the Royal Astronomical Society 299, no. 4 (October 1, 1998): 1215–19. http://dx.doi.org/10.1046/j.1365-8711.1998.01881.x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
8

Brewer, B. J., and G. F. Lewis. "The Einstein Ring 0047‐2808 Revisited: A Bayesian Inversion." Astrophysical Journal 651, no. 1 (November 2006): 8–13. http://dx.doi.org/10.1086/507475.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
9

Wisotzki, L., P. L. Schechter, H. W. Chen, D. Richstone, K. Jahnke, S. F. Sánchez, and D. Reimers. "HE 0047-1756: A new gravitationally lensed double QSO." Astronomy & Astrophysics 419, no. 3 (May 7, 2004): L31—L34. http://dx.doi.org/10.1051/0004-6361:20040131.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
10

Riesgo-Tirado, H., and J. A. López. "H 2–12, a Misidentified Planetary Nebula in Kepler's SNR." Symposium - International Astronomical Union 209 (2003): 45. http://dx.doi.org/10.1017/s0074180900208012.

Повний текст джерела
Анотація:
H 2–12 (PN 004.5+06.8) is classified as a true or probable planetary nebula (Acker et al. 1992). We obtained narrow-band imagery and long-slit echelle spectra from several positions across H 2–12. It is shown that H 2–12 is associated with one of the brightest condensations located at the periphery of Kepler's SNR. Thus, H 2–12 should be noted as a misclassified PN.
Стилі APA, Harvard, Vancouver, ISO та ін.
11

BINNER, Rolf, and Marc JUNGE. "Wie Dder terror “Gross” wurde: Massenmord und Lagerhaft nach Befehl 00447." Cahiers du monde russe 42, no. 42/2-4 (April 1, 2001): 557–614. http://dx.doi.org/10.4000/monderusse.8470.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
12

Ellman, Michael. "Regional Influences on the Formulation and Implementation of NKVD Order 00447." Europe-Asia Studies 62, no. 6 (July 12, 2010): 915–31. http://dx.doi.org/10.1080/09668136.2010.489254.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
13

Seleznev, A. G., and I. A. Selezneva. "Ecovillages: a modernist version of rural development (on the example of the Omsk region)." Ethnography of Altai and Adjacent Territories 10 (2020): 70–73. http://dx.doi.org/10.37386/2687-0592-2020-10-70-73.

Повний текст джерела
Анотація:
Results of the ethnographic study of Omsk region ecological movements and ecovillages fulfilled under the RFBR project №19-09-00487 are presented in the paper. The specificity of sociological and anthropological approaches to the study of ecomovements and ecovillages has defined. The main attention is paid to the ideological motives of ecovillages organization. The classification is based on the level of association with other settlements, or other forms of human activity was suggested also.
Стилі APA, Harvard, Vancouver, ISO та ін.
14

Slichter, Sherrill J., Larry J. Dumont, Jose A. Cancelas, Terry Gernsheimer, Zbigniew Szczepiorkowski, Nancy M. Dunbar, Stephen Medlin, et al. "Treatment of Bleeding in Severely Thrombocytopenic Patients with Transfusion of Dimethyl Sulfoxide (DMSO) Cryopreserved Platelets (CPP) Is Safe - Report of a Phase 1 Dose Escalation Safety Trial." Blood 128, no. 22 (December 2, 2016): 1030. http://dx.doi.org/10.1182/blood.v128.22.1030.1030.

Повний текст джерела
Анотація:
Abstract Availability of platelets (plts) is severely limited by shelf life in some military as well as civilian settings. Additionally, some bleeding, thrombocytopenic patients do not have a therapeutic response to a standard plt transfusion. Methods for cryopreservation of apheresis plts for up to two years in 6% DMSO at <-65°C (CPP) have been developed and evaluated by in vitro assays and by in vivo infusions in non-human primates, in a few controlled human trials, and in field military operations. However, FDA has not yet approved CPP for routine use. Autologous radiolabeled CPP in healthy volunteers (n=32) had average plt recoveries of 33 ± 10% and survivals of 7.5 ± 1.2 days, and these results were 52 ± 12% and 89 ± 15%, respectively, of the same volunteers' fresh radiolabeled plts. The in vitro phenotype of CPP showed higher granule secretion, phosphotidylserine expression, and plt microparticles and poorer responses to common plt agonists compared to standard room temperature stored plts. These data suggest that transfused CPP might lead to an accelerated and enhanced clotting process in vivo. Our objective was to evaluate the safety of transfused CPP in a Phase-1 dose escalation trial. Eligibility criteria were hospitalized thrombocytopenic hematology/oncology patients with active World Health Organization (WHO) Grade 2 or greater bleeding that was, in most patients, uncontrolled by standard plts, no history of unprovoked thrombotic events, and no indication of active DIC. Fifty-nine patients consented and 28 were transfused with ½ CPP unit (n=5), one CPP unit (n=7), two CPP units (n=6), and three CPP units (n=6). One thawed single apheresis CPP unit contained 2.5 x 1011 ± 4.2 x 1010 plts in 50 ± 4 ml. In addition, one standard apheresis plt unit was randomly given to patients enrolled in each cohort (n=4). The study conformed to the Declaration of Helsinki and was listed on clinical trials.gov (NCT02078284). Patients were monitored for six days post-transfusion for adverse events (AEs) including clinical assessments for signs or symptoms of thrombosis and specific laboratory assays: prothrombin time (PT), partial thromboplastin time (aPTT), D-dimer, fibrinogen, prothrombin fragments 1 + 2 (F1+2), antithrombin, thrombin antithrombin (TAT), thrombin generation (TGT), and thromboelastography (TEG). All safety data were reviewed by an independent data safety monitoring committee prior to escalation to the next higher dose cohort. No thrombotic events occurred after transfusion of CPP units. Five serious AEs were reported, and none were associated with the CPP transfusion but, rather, were related to worsening of the patients' underlying medical conditions. Of 38 AEs, 5 were, at least, possibly related to a CPP transfusion and included DMSO skin odor following a ½ CPP unit and three CPP units (n=2), mild fever and chills in the same patient after one CPP unit (n=2), and moderate headache the next day following transfusion of three CPP units (n=1). As expected in this clinically-ill patient population, D-dimer, fibrinogen, F1+2, aPTT, and TAT averaged higher than the upper limit of normal prior to transfusion and remained similar following transfusion. TGT and TEG were suppressed pre-transfusion and were improved towards normal levels following transfusion of either CPP or standard plts. There was no induction of a post-transfusion hypercoagulable state in any patient based on laboratory results. Modest increases in corrected plts count increments (x 103/mm3) were observed following CPP transfusion (one CPP unit gave CCI's of 2.3 ± 3.5; two CPP units 4.2 ± 2.8; and three CPP units 5.6 ± 2.3) compared with 21.1 ± 3.6 after one unit of standard apheresis plts. Notably, all patients had stabilization or improvement of their bleeding following a CPP transfusion including one patient with Grade 4 CNS bleeding who had resolution of neurologic symptoms with no further plt transfusions, and four patients (17%) had WHO bleeding downgraded. In conclusion, the infusion of up to three sequential units of CPP in patients with severe thrombocytopenia and active bleeding was safe without any evidence of thrombotic complications despite CPP having a procoagulant phenotype resulting from the cryopreservation process. CPP may be efficacious to stop bleeding in thrombocytopenic patients as suggested by stabilization or downgrading of WHO bleeding grades. Phase 2/3 efficacy clinical trials are now indicated. Disclosures Slichter: NHLBI / NIH: Research Funding; Genentech: Research Funding; Cerus Corporation: Research Funding; Terumo BCT: Research Funding; Cellphire: Research Funding; Department of Defense / US Army Medical Research and Material Command: Research Funding; Megakaryon: Consultancy, Membership on an entity's Board of Directors or advisory committees, Other: Stock options. Dumont:US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding. Cancelas:New Health Sciences, Inc.: Membership on an entity's Board of Directors or advisory committees; US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding; National Institutes of Health: Research Funding; Terumo BCT: Research Funding; Cerus Corporation: Research Funding; Haemonetics, Inc.: Research Funding; Citra Labs, Inc.: Research Funding; Cellphire, Inc.: Membership on an entity's Board of Directors or advisory committees; William & Lawrence Hughes Foundation: Research Funding; Leukemia & Lymphoma Society of North America: Research Funding. Gernsheimer:Department of Defense: Research Funding; NHLBI / NIH: Research Funding. Szczepiorkowski:Fresenius Kabi: Consultancy, Membership on an entity's Board of Directors or advisory committees; Grifols: Consultancy, Research Funding; Terumo BCT: Consultancy; Cerus Corporation: Research Funding; Erydel: Research Funding; Citra Labs: Research Funding; US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding; American Association of Blood Banks: Other: President-Elect. Dunbar:Verax Biomedical: Membership on an entity's Board of Directors or advisory committees; US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding. Jones:US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding. Rugg:US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding. Prakash:US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding. Hmel:US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding. Ransom:US Army Medical Research and Material Command (Award W81XWH-15-C-0047) / Department of Defense: Research Funding.
Стилі APA, Harvard, Vancouver, ISO та ін.
15

Agrawal, L., H. Moore, and J. Vaught. "MC13-0047 Serum and tissue biomarkers for cancer biospecimen integrity." European Journal of Cancer 49 (November 2013): S25. http://dx.doi.org/10.1016/s0959-8049(13)70159-x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
16

Rohaeti, E., A. Putri, K. S. Budiasih, N. A. Ariyanti, A. S. N. Annisa, and E. Kasmudjiastuti. "Preparation of silver nanoparticle by green synthesis and application to leather in enhancements of antimicrobial activity of leather." Journal of Physics: Conference Series 2098, no. 1 (November 1, 2021): 012037. http://dx.doi.org/10.1088/1742-6596/2098/1/012037.

Повний текст джерела
Анотація:
Abstract The objectives of this study were to prepare nanoparticle by using extract of Tectona grandis L. leaf and to deposit nanoparticle on goat leather via ex situ method, and also to characterize the antimicrobial activity of modified goat leather. The stages in this study were preparing of silver nanoparticles via green synthesis method by using extract of teak leaf, characterizing of nanoparticle by using a UV-Vis spectrophotometer and Particle Size Analyzer (PSA), impregnating the nanoparticle on the pickle leather by ex situ method, and analysing the antibacterial and antifungal activities of modified leather by the diffusion method. The silver nanoparticles were greenish brown in colour, having absorption at the wavelengths of 449 nm which indicator the formation of silver nanoparticles. The silver nanoparticles have an average particle size of 109.9 nm. The results of antimicrobial tests against the bacteria Staphylococcus epidermidis DNCC 6018, Escherichia coli FNCC 0047, and the fungus Candida albicans ANCC 0048 showed that all variations of the leather have different abilities in inhibiting the growth of the bacteria and the fungi. The pickle leathers after modification with nanoparticle Ag showed the highest antibacterial activities against Staphylococcus epidermidis DNCC 6018 and Escherichia coli FNCC 0047.
Стилі APA, Harvard, Vancouver, ISO та ін.
17

Magnucki, Krzysztof, Paweł Kuligowski, and Marcin Kruś. "Pudła wagonów osobowych: wybrane zagadnienia." Rail Vehicles, no. 4 (October 2, 2011): 29–32. http://dx.doi.org/10.53502/rail-139536.

Повний текст джерела
Анотація:
W pracy scharakteryzowano rozwój budowy taboru wagonów osobowych na ziemiach polskich od drugiej połowy XIX wieku. Zwrócono szczególną uwagę na różnorodność wyposażenia i przeznaczenia wagonów pasażerskich, a także ewolucję konstrukcji nośnych od rozwiązań drewnianych do współczesnych stalowych cienkościennych. Praca jest realizowana w ramach projektu rozwojowego nr R 10 0047/06/2009 „Konstrukcja pojazdu szynowego z zastosowaniem najnowszych lekkich materiałów o wysokich parametrach wytrzymałościowych i o minimalnym oddziaływaniu na środowisko”
Стилі APA, Harvard, Vancouver, ISO та ін.
18

Futamase, T., and T. Hamana. "Constraint on the Cosmological Constant by Einstein Ring System 0047-2808." Progress of Theoretical Physics 102, no. 5 (November 1, 1999): 1037–41. http://dx.doi.org/10.1143/ptp.102.1037.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
19

Adhya, D., L. Dutan, D. Srivastava, and S. Baron-Cohen. "P.0047 FGF2 dysregulation induces atypical neural rosette formation in autism." European Neuropsychopharmacology 53 (December 2021): S34—S35. http://dx.doi.org/10.1016/j.euroneuro.2021.10.052.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
20

Trent, M., S. Chung, B. Harris, S. Huettner, A. Butz, and C. Gaydos. "004.3 Adolescent care-seeking behaviour after notification of positive sexually transmitted infection results." Sexually Transmitted Infections 91, Suppl 2 (September 2015): A33.2—A33. http://dx.doi.org/10.1136/sextrans-2015-052270.99.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
21

Cohen, A. F., S. Mitsudo, and R. J. Ruben. "The anterior cricoid split exlored via the canine model, preliminary studies (POR 00477)." International Journal of Pediatric Otorhinolaryngology 14, no. 2-3 (December 1987): 176–85. http://dx.doi.org/10.1016/0165-5876(87)90029-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
22

Millon, M., F. Courbin, V. Bonvin, E. Buckley-Geer, C. D. Fassnacht, J. Frieman, P. J. Marshall, et al. "TDCOSMO." Astronomy & Astrophysics 642 (October 2020): A193. http://dx.doi.org/10.1051/0004-6361/202038698.

Повний текст джерела
Анотація:
We present six new time-delay measurements obtained from Rc-band monitoring data acquired at the Max Planck Institute for Astrophysics (MPIA) 2.2 m telescope at La Silla observatory between October 2016 and February 2020. The lensed quasars HE 0047−1756, WG 0214−2105, DES 0407−5006, 2M 1134−2103, PSJ 1606−2333, and DES 2325−5229 were observed almost daily at high signal-to-noise ratio to obtain high-quality light curves where we can record fast and small-amplitude variations of the quasars. We measured time delays between all pairs of multiple images with only one or two seasons of monitoring with the exception of the time delays relative to image D of PSJ 1606−2333. The most precise estimate was obtained for the delay between image A and image B of DES 0407−5006, where τAB = −128.4−3.8+3.5 d (2.8% precision) including systematics due to extrinsic variability in the light curves. For HE 0047−1756, we combined our high-cadence data with measurements from decade-long light curves from previous COSMOGRAIL campaigns, and reach a precision of 0.9 d on the final measurement. The present work demonstrates the feasibility of measuring time delays in lensed quasars in only one or two seasons, provided high signal-to-noise ratio data are obtained at a cadence close to daily.
Стилі APA, Harvard, Vancouver, ISO та ін.
23

Назипов, Д. В., та А. Е. Никифоров. "Структура и динамика решетки Lu-=SUB=-2-=/SUB=-Si-=SUB=-2-=/SUB=-O-=SUB=-7-=/SUB=-: ab initio расчет". Физика твердого тела 59, № 1 (2017): 121. http://dx.doi.org/10.21883/ftt.2017.01.43961.133.

Повний текст джерела
Анотація:
Проведены ab initio расчеты кристаллической структуры и спектра комбинационного рассеяния света (КРС) монокристалла пиросиликата лютеция Lu2Si2O7. Определены типы фундаментальных колебаний, их частоты и интенсивности в спектре КРС для двух поляризаций. Расчет проводился в рамках теории функционала плотности (DFT) с использованием гибридных функционалов. Методом изотопического замещения определены участвующие в колебаниях ионы. Результаты расчета хорошо согласуются с экспериментом. Работа выполнена при поддержке Министерства образования и науки РФ (проект N 3.571.2014/K), Правительства РФ (контракт N 02.А03.21.0006, постановление N 211), а также фонда РФФИ в рамках научного проекта N 16-33-00437 мол\_а. Для расчетов использовался вычислительный кластер ИММ УрО РАН. DOI: 10.21883/FTT.2017.01.43961.133
Стилі APA, Harvard, Vancouver, ISO та ін.
24

Chatigny, P., C. Bélanger, É. Poulin, and L. Beaulieu. "OC-0047 Multi-criteria optimization integrating catheter optimization for prostate HDR brachytherapy." Radiotherapy and Oncology 158 (May 2021): S35—S37. http://dx.doi.org/10.1016/s0167-8140(21)06289-7.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
25

Francis, SC, C. Hansen, J. Irani, A. Andreasen, V. Jespers, S. Nnko, T. Crucitti, C. Changalucha, D. Watson-Jones, and A. Buve. "004.6 High prevalence of bacterial vaginosis among adolescent girls attending secondary school in tanzania." Sexually Transmitted Infections 91, Suppl 2 (September 2015): A34.2—A35. http://dx.doi.org/10.1136/sextrans-2015-052270.102.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
26

Magnucki, Krzysztof, Paweł Kuligowski, and Leszek Wittenbeck. "Zginanie sprężystych belek trójwarstwowych z rdzeniem falistym." Rail Vehicles, no. 1 (February 1, 2012): 1–4. http://dx.doi.org/10.53502/rail-139413.

Повний текст джерела
Анотація:
W pracy opisano model teoretyczny belki-pasma trójwarstwowego z rdzeniem wykonanym z cienkiej pofałdowanej blachy. Sformułowano sztywności tego pasma i wyznaczono jego ugięcia. Wyróżniono dwa kierunki zginania walcowego pasma, jeden zgodny z kierunkiem pofałdowania rdzenia, drugi prostopadły do pofałdowania. Ugięcia wyznaczone analitycznie porównano z ugięciami uzyskanych doświadczalnie. Wykazano poprawność modelu analitycznego w zakresie zginania pasma płytowego – belki trójwarstwowej w dwóch charakterystycznych kierunkach. Praca jest realizowana w ramach projektu rozwojowego nr R 10 0047/06/2009 „Konstrukcja pojazdu szynowego z zastosowaniem najnowszych lekkich materiałów o wysokich parametrach wytrzymałościowych i o minimalnym oddziaływaniu na środowisko”
Стилі APA, Harvard, Vancouver, ISO та ін.
27

Caprioglio, Diego, Daiana Mattoteia, Orazio Taglialatela-Scafati, Eduardo Muñoz, and Giovanni Appendino. "Cannabinoquinones: Synthesis and Biological Profile." Biomolecules 11, no. 7 (July 5, 2021): 991. http://dx.doi.org/10.3390/biom11070991.

Повний текст джерела
Анотація:
Neutral cannabinoids are oxidatively unstable and are converted into quinone derivatives by atmospheric- and/or chemical oxidative dearomatization. The study of cannabinoquinones has long been plagued by their lability toward additional oxidative degradation, but full substitution of the quinone ring, as well as the introduction of steric hindrance on the alkyl substituent, have provided sufficient stability for a systematic investigation of their bioactivity and for further clinical development. These studies culminated in the discovery of the aminocannabinoquinone VCE-004.8 (5), a compound under phase 2 clinical development with orphan drug status by EMA and FDA for the management of scleroderma. The synthesis and rich chemistry of these compounds will be described, summarizing their biological profile and clinical potential.
Стилі APA, Harvard, Vancouver, ISO та ін.
28

Alber, M., N. Schwenzer, H. Schmidt, A. C. Müller, and D. Thorwarth. "OC-0047: Dose painting under consideration of uncertainties of combined multiparametric functional images." Radiotherapy and Oncology 111 (2014): S17. http://dx.doi.org/10.1016/s0167-8140(15)30152-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
29

Ordaz-Johnson, Omar, Andrew W. McHill, Saurabh S. Thosar, Nicole P. Bowles, Alec M. Berman, Maya X. Herzig, Sally A. Roberts, et al. "0047 Circadian Regulation of Hunger is Similar in Lean and Non-lean Individuals." Sleep 42, Supplement_1 (April 2019): A19—A20. http://dx.doi.org/10.1093/sleep/zsz067.046.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
30

Dikmen, Z. Gunnur, Ginelle C. Gellert, Pakize Dogan, Heejeong Yoon, Young Bok Lee, Chang Ho Ahn та Jerry W. Shay. "In vivo and in vitro effects of a HIF-1α inhibitor, RX-0047". Journal of Cellular Biochemistry 104, № 3 (2008): 985–94. http://dx.doi.org/10.1002/jcb.21681.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
31

Baptista, Patricia, Carolina Bernardes, Thatiana Coa, Vanda Felli, Marcelo Pustiglione, and Ruth Munhoz. "0047 Health disorders between nursing staff in a public hospital of Sao Paulo." Occupational and Environmental Medicine 71, Suppl 1 (June 2014): A64.3—A65. http://dx.doi.org/10.1136/oemed-2014-102362.201.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
32

"96/00417 Attempting immortality." Fuel and Energy Abstracts 37, no. 1 (January 1996): 25. http://dx.doi.org/10.1016/0140-6701(96)86588-x.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
33

"96/00447 EMC compliance — PLCs ok?" Fuel and Energy Abstracts 37, no. 1 (January 1996): 27. http://dx.doi.org/10.1016/0140-6701(96)86626-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
34

Ju, Kou-San, Xiafei Zhang, and Marie A. Elliot. "New Kid on the Block: LmbU Expands the Repertoire of Specialized Metabolic Regulators in Streptomyces." Journal of Bacteriology 200, no. 2 (October 30, 2017). http://dx.doi.org/10.1128/jb.00559-17.

Повний текст джерела
Анотація:
ABSTRACT Streptomyces has an extensive natural product repertoire, including most of the naturally derived antibiotics. Understanding the control of natural product biosynthesis is central to antibiotic discovery and production optimization. Here, Hou et al. (J. Bacteriol. 200:00447-17, 2018, https://doi.org/10.1128/JB.00447-17) report the identification and characterization of a novel regulator—LmbU—that functions primarily as an activator of lincomycin production in Streptomyces lincolnensis. Importantly, members of this new regulator family are associated with natural product biosynthetic clusters throughout the streptomycetes and their actinomycete relatives.
Стилі APA, Harvard, Vancouver, ISO та ін.
35

"10.1007/s10697-007-0047-1." CrossRef Listing of Deleted DOIs 1 (2000). http://dx.doi.org/10.1007/s10697-007-0047-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
36

Savola, Paula, Sofie Lundgren, Mikko A. I. Keränen, Henrikki Almusa, Pekka Ellonen, Marjatta Leirisalo-Repo, Tiina Kelkka, and Satu Mustjoki. "Author Correction: Clonal hematopoiesis in patients with rheumatoid arthritis." Blood Cancer Journal 11, no. 2 (February 2021). http://dx.doi.org/10.1038/s41408-021-00427-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
37

Wang, Qi, Abbass Hamadeh, Roman Verba, Vitaliy Lomakin, Morteza Mohseni, Burkard Hillebrands, Andrii V. Chumak, and Philipp Pirro. "Author Correction: A nonlinear magnonic nano-ring resonator." npj Computational Materials 7, no. 1 (February 1, 2021). http://dx.doi.org/10.1038/s41524-021-00497-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
38

Arias-Medina, Paúl. "Retraction Note: Psychometric properties of the self-report version of the strengths and difficulties questionnaire in the Ecuadorian context: an evaluation of four models." BMC Psychology 8, no. 1 (December 2020). http://dx.doi.org/10.1186/s40359-020-00487-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
39

"97/00427 Performance-based nuclear safety regulation." Fuel and Energy Abstracts 38, no. 1 (January 1997): 31. http://dx.doi.org/10.1016/s0140-6701(97)80203-2.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
40

"05/00467 Modeling of lithium-ion batteries." Fuel and Energy Abstracts 46, no. 1 (January 2005): 61. http://dx.doi.org/10.1016/s0140-6701(05)80468-0.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
41

"99/00427 Reactor pressure vessel integrity program." Fuel and Energy Abstracts 40, no. 1 (January 1999): 42. http://dx.doi.org/10.1016/s0140-6701(99)92700-5.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
42

"98/00427 Enzymes in lignocellulosic biomass conversion." Fuel and Energy Abstracts 39, no. 1 (January 1998): 36. http://dx.doi.org/10.1016/s0140-6701(97)85700-1.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
43

"98/00467 Performance of liquid convective diodes." Fuel and Energy Abstracts 39, no. 1 (January 1998): 40. http://dx.doi.org/10.1016/s0140-6701(97)85741-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
44

"98/00477 Capacity factor of wind turbines." Fuel and Energy Abstracts 39, no. 1 (January 1998): 41. http://dx.doi.org/10.1016/s0140-6701(97)85746-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
45

"95/00407 Solidification of Incinerator fly ash." Fuel and Energy Abstracts 36, no. 1 (January 1995): 23. http://dx.doi.org/10.1016/0140-6701(95)95657-3.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
46

"96/00497 Voltage transients on restricted systems." Fuel and Energy Abstracts 37, no. 1 (January 1996): 29. http://dx.doi.org/10.1016/0140-6701(96)90954-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
47

"00/00467 Thermodynamic optimization of a heat exchanger." Fuel and Energy Abstracts 41, no. 1 (January 2000): 49. http://dx.doi.org/10.1016/s0140-6701(00)95253-6.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
48

"97/00457 Phosphoric acid fuel cells in Japan." Fuel and Energy Abstracts 38, no. 1 (January 1997): 34. http://dx.doi.org/10.1016/s0140-6701(97)80237-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
49

"05/00407 Defining existence values of environmental resources." Fuel and Energy Abstracts 46, no. 1 (January 2005): 55. http://dx.doi.org/10.1016/s0140-6701(05)80408-4.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
50

"04/00407 A partially static turbine - first experimental results." Fuel and Energy Abstracts 45, no. 1 (January 2004): 48. http://dx.doi.org/10.1016/s0140-6701(04)91609-8.

Повний текст джерела
Стилі APA, Harvard, Vancouver, ISO та ін.
Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!

До бібліографії